Methodological frontiers in vaccine safety: qualifying available evidence for rare events, use of distributed data networks to monitor vaccine safety issues, and monitoring the safety of pregnancy interventions

While vaccines are rigorously tested for safety and efficacy in clinical trials, these trials do not include enough subjects to detect rare adverse events, and they generally exclude special populations such as pregnant women. It is therefore necessary to conduct postmarketing vaccine safety assessm...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:BMJ Glob Health
Egile Nagusiak: Dodd, Caitlin, Andrews, Nick, Petousis-Harris, Helen, Sturkenboom, Miriam, Omer, Saad B, Black, Steven
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BMJ Publishing Group 2021
Gaiak:
Analysis
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC8137251/
https://ncbi.nlm.nih.gov/pubmed/34011501
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjgh-2020-003540
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak